Type |
Details |
Score |
Publication |
First Author: |
Bellacchio E |
Year: |
2013 |
Journal: |
J Cell Physiol |
Title: |
Understanding the targeting of the RB family proteins by viral oncoproteins to defeat their oncogenic machinery. |
Volume: |
228 |
Issue: |
2 |
Pages: |
285-91 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This group represents adenoviral early E1A proteins. The E1A protein is responsible for the transcriptional activation of the early genes with in the viral genome at the start of the infection process as well as some cellular genes [].E1A disrupts the function of host retinoblastoma protein RB1/pRb, which is a key regulator of the cell cycle []. It also induces the disassembly of the E2F1 transcription factors from RB1 by direct competition for the same binding site on RB1, with subsequent transcriptional activation of E2F1-regulated S-phase genes []. Inactivation of the ability of RB1 to arrest the cell cycle is critical for cellular transformation, uncontrolled cellular growth and proliferation induced by viral infection. The stimulation of the progression from G1 to S phase allows the virus to efficiently use the cellular DNA replicating machinery to achieve viral genome replication. |
|
•
•
•
•
•
|
Publication |
First Author: |
Kujuro Y |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. |
Volume: |
107 |
Issue: |
18 |
Pages: |
8259-64 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
148
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Yue CM |
Year: |
2003 |
Journal: |
World J Gastroenterol |
Title: |
Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. |
Volume: |
9 |
Issue: |
6 |
Pages: |
1174-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tadross JA |
Year: |
2010 |
Journal: |
Br J Pharmacol |
Title: |
Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in rats. |
Volume: |
159 |
Issue: |
8 |
Pages: |
1663-71 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Augurin is alternatively named oesophageal cancer-related gene 4 protein. The function of this family of transmembrane proteins is to induce the senescence of oligodendrocyte and neural precursor cells, characterised by G1 arrest, RB1 dephosphorylation and accelerated CCND1 and CCND3 proteasomal degradation [, ]. Augurin is a posible hormone that has been found to stimulate the release of adrenocorticotropic hormone (ACTH) via the release of hypothalamic corticotrophin-releasing factor (CRF) []. |
|
•
•
•
•
•
|
Genotype |
Symbol: |
E2f1/E2f1 Rb1/Rb1 Tg(Rb1)1Blg/? |
Background: |
involves: 129S2/SvPas * 129S4/SvJae |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn1a/Cdkn1a Rb1/Rb1 Tg(Rb1)1Blg/? |
Background: |
involves: 129S2/SvPas |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn1a/Cdkn1a Rb1/Rb1<+> Tg(Rb1)1Blg/? |
Background: |
involves: 129S2/SvPas |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Maire CL |
Year: |
2011 |
Journal: |
Cancer Cell |
Title: |
Glioma models: new GEMMs add "class" with genomic and expression correlations. |
Volume: |
19 |
Issue: |
3 |
Pages: |
295-7 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion #, Terry Van Dyke |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 3, Terry Van Dyke |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 4, Terry Van Dyke |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 5, Terry Van Dyke |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang B |
Year: |
2012 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Liver tumor formation by a mutant retinoblastoma protein in the transgenic mice is caused by an upregulation of c-Myc target genes. |
Volume: |
417 |
Issue: |
1 |
Pages: |
601-6 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1 |
Background: |
either: 129P2/OlaHsd-Rb1 or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N) |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1 |
Background: |
either: 129P2/OlaHsd-Rb1 or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N) |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1<+> |
Background: |
either: 129P2/OlaHsd-Rb1 or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N) |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1<+> |
Background: |
either: 129P2/OlaHsd-Rb1 or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N) |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Hnf1a-RB1*)XMiu/? |
Background: |
Not Specified |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Tarang S |
Year: |
2015 |
Journal: |
Front Cell Neurosci |
Title: |
Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model. |
Volume: |
9 |
|
Pages: |
52 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Apaf1/Apaf1 Rb1/Rb1 Tg(Rb1)1Blg/? |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1 Tg(Rb1)1Blg/? Trp53/Trp53 |
Background: |
involves: 129S2/SvPas |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Lemieux N |
Year: |
1992 |
Journal: |
Cytogenet Cell Genet |
Title: |
New gene assignments to rabbit chromosomes; implications for chromosome evolution. |
Volume: |
61 |
Issue: |
2 |
Pages: |
132-4 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Calca/Calca<+> Trp53/Trp53 Rb1/Rb1 Pten/Pten |
Background: |
involves: 129 * 129P2/OlaHsd * 129S4/SvJae * BALB/c * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1 Trp53/Trp53 Tg(BGLAP-cre)1Clem/? |
Background: |
involves: 129 * 129P2/OlaHsd * FVB/NJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nell1/Nell1 Rb1/Rb1 Trp53/Trp53 Tg(BGLAP-cre)1Clem/? |
Background: |
involves: 129 * FVB/NJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Rb1/Rb1 Tg(Prdm1-cre)1Masu/? |
Background: |
involves: C57BL/6J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Simin K |
Year: |
2004 |
Journal: |
PLoS Biol |
Title: |
pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. |
Volume: |
2 |
Issue: |
2 |
Pages: |
E22 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, Brenda L Gallie |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1 Rbl1/Rbl1 Trp53/Trp53 Tg(Chx10-EGFP/cre,-ALPP)2Clc/? |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1 Rbl1/Rbl1<+> Trp53/Trp53 Tg(Chx10-EGFP/cre,-ALPP)2Clc/? |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1 Rbl1/Rbl1<+> Tg(Chx10-EGFP/cre,-ALPP)2Clc/? |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Rb1/Rb1 Tg(Pbsn-cre)4Prb/? |
Background: |
involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Rb1/Rb1<+> Tg(Pbsn-cre)4Prb/? |
Background: |
involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pten/Pten Rb1/Rb1 Tg(Pbsn-cre)4Prb/? |
Background: |
involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rb1/Rb1 Rbl1/Rbl1 Trp53/Trp53 Tg(Chx10-EGFP/cre,-ALPP)2Clc/? |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Sánchez ER |
Year: |
1986 |
Journal: |
J Hered |
Title: |
Wild-derived Robertsonian translocation in mice. Chromosome 17, Rb (16:17)7, shows novel interactions with t-alleles. |
Volume: |
77 |
Issue: |
5 |
Pages: |
290-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Safronova LD |
Year: |
1993 |
Journal: |
Genetika |
Title: |
[Disturbance of the relationship of transmission in male mice carrying the translocation Rb(8,17)1 Iem in combination with t-haplotypes]. |
Volume: |
29 |
Issue: |
12 |
Pages: |
1992-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen D |
Year: |
2002 |
Journal: |
Cancer Res |
Title: |
Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN. |
Volume: |
62 |
Issue: |
4 |
Pages: |
967-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang Y |
Year: |
2009 |
Journal: |
Cancer Prev Res (Phila) |
Title: |
Preventive effects of bexarotene and budesonide in a genetically engineered mouse model of small cell lung cancer. |
Volume: |
2 |
Issue: |
12 |
Pages: |
1059-64 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 14, Sonia M Rocha-Sanchez |
Allele Type: |
Transgenic |
Attribute String: |
Dominant negative, Epitope tag, Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Publication |
First Author: |
Romero R |
Year: |
2024 |
Journal: |
Nat Cancer |
Title: |
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1. |
Volume: |
5 |
Issue: |
11 |
Pages: |
1641-1659 |
|
•
•
•
•
•
|
Publication |
First Author: |
Annunziato S |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer. |
Volume: |
10 |
Issue: |
1 |
Pages: |
397 |
|
•
•
•
•
•
|
Publication |
First Author: |
Arora M |
Year: |
2023 |
Journal: |
Cell |
Title: |
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity. |
Volume: |
186 |
Issue: |
12 |
Pages: |
2628-2643.e21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gong Y |
Year: |
2023 |
Journal: |
Dev Cell |
Title: |
Loss of RanGAP1 drives chromosome instability and rapid tumorigenesis of osteosarcoma. |
Volume: |
58 |
Issue: |
3 |
Pages: |
192-210.e11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee S |
Year: |
2024 |
Journal: |
Cell Rep |
Title: |
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis. |
Volume: |
43 |
Issue: |
5 |
Pages: |
114146 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fang L |
Year: |
2022 |
Journal: |
Cancer Gene Ther |
Title: |
TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence. |
Volume: |
29 |
Issue: |
10 |
Pages: |
1463-1476 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang ME |
Year: |
2023 |
Journal: |
J Clin Invest |
Title: |
RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis. |
Volume: |
133 |
Issue: |
10 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Chow RD |
Year: |
2017 |
Journal: |
Nat Neurosci |
Title: |
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. |
Volume: |
20 |
Issue: |
10 |
Pages: |
1329-1341 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brunelli JP |
Year: |
1999 |
Journal: |
Gene |
Title: |
Sequence, expression and genetic mapping of a rainbow trout retinoblastoma cDNA. |
Volume: |
226 |
Issue: |
2 |
Pages: |
175-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bremner R |
Year: |
2010 |
Journal: |
Cancer Res |
Title: |
Cyclins, Cdks, E2f, Skp2, and more at the first international RB Tumor Suppressor Meeting. |
Volume: |
70 |
Issue: |
15 |
Pages: |
6114-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peifer M |
Year: |
2012 |
Journal: |
Nat Genet |
Title: |
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. |
Volume: |
44 |
Issue: |
10 |
Pages: |
1104-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Holmfeldt L |
Year: |
2013 |
Journal: |
Nat Genet |
Title: |
The genomic landscape of hypodiploid acute lymphoblastic leukemia. |
Volume: |
45 |
Issue: |
3 |
Pages: |
242-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hinds PW |
Year: |
2014 |
Journal: |
Cancer Discov |
Title: |
A little pRB can lead to big problems. |
Volume: |
4 |
Issue: |
7 |
Pages: |
764-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhu L |
Year: |
2015 |
Journal: |
Oncogene |
Title: |
Antitumor mechanisms when pRb and p53 are genetically inactivated. |
Volume: |
34 |
Issue: |
35 |
Pages: |
4547-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Akamatsu S |
Year: |
2015 |
Journal: |
Cell Rep |
Title: |
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer. |
Volume: |
12 |
Issue: |
6 |
Pages: |
922-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Papale A |
Year: |
2016 |
Journal: |
Elife |
Title: |
Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors. |
Volume: |
5 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Hopkins J |
Year: |
2022 |
Journal: |
Cancers (Basel) |
Title: |
PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression. |
Volume: |
14 |
Issue: |
19 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Giaccone G |
Year: |
2023 |
Journal: |
Semin Cancer Biol |
Title: |
Current knowledge of small cell lung cancer transformation from non-small cell lung cancer. |
Volume: |
94 |
|
Pages: |
1-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jin Y |
Year: |
2022 |
Journal: |
Natl Sci Rev |
Title: |
Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis. |
Volume: |
9 |
Issue: |
7 |
Pages: |
nwab232 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, mutant stock |
|
•
•
•
•
•
|
Publication |
First Author: |
Yochum GS |
Year: |
2002 |
Journal: |
Mol Cell Biol |
Title: |
Role for the mortality factors MORF4, MRGX, and MRG15 in transcriptional repression via associations with Pf1, mSin3A, and Transducin-Like Enhancer of Split. |
Volume: |
22 |
Issue: |
22 |
Pages: |
7868-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tominaga K |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
MRGX is a novel transcriptional regulator that exhibits activation or repression of the B-myb promoter in a cell type-dependent manner. |
Volume: |
278 |
Issue: |
49 |
Pages: |
49618-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saddic LA |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
Methylation of the retinoblastoma tumor suppressor by SMYD2. |
Volume: |
285 |
Issue: |
48 |
Pages: |
37733-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang J |
Year: |
2006 |
Journal: |
Nature |
Title: |
Repression of p53 activity by Smyd2-mediated methylation. |
Volume: |
444 |
Issue: |
7119 |
Pages: |
629-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Donlin LT |
Year: |
2012 |
Journal: |
Genes Dev |
Title: |
Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization. |
Volume: |
26 |
Issue: |
2 |
Pages: |
114-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ohtomo-Oda R |
Year: |
2016 |
Journal: |
Hum Pathol |
Title: |
SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas. |
Volume: |
49 |
|
Pages: |
145-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bagislar S |
Year: |
2016 |
Journal: |
Oncotarget |
Title: |
Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis. |
Volume: |
7 |
Issue: |
41 |
Pages: |
66398-66415 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Mortality factor 4-like protein 2 (MORF4L2 or MRGX) is a component of the NuA4 histone acetyltransferase complex []and the MSIN3A complex which acts to repress transcription by deacetylation of nucleosomal histones []. MRGX interacts with MRFAP1 and RB1 and represses the B-myb promoter in EJ cells but activates it in HeLa cells []. MRGX contains an MRG domain.The NuA4 histone acetyltransferase complex (also known as the TRRAP/TIP60-containing histone acetyltransferase complex) acetylates nucleosomal histones H4 and H2A thereby activating selected genes for transcription and is a a key regulator of transcription, cellular response to DNA damage and cell cycle control []. In yeast, where the complex was first identified, NuA4 consists of at least ACT1, ARP4, YAF9, VID21, SWC4, EAF3, EAF5, EAF6, EAF7, EPL1, ESA1, TRA1 and YNG2 []. In humans, the complex is composed of the histone acetyltransferase KAT5 (also known as TIP60) plus the subunits EP400, TRRAP/PAF400, BRD8/SMAP, EPC1, MAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP, YEATS4/GAS41, VPS72/YL1 and MEAF6 []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SET domain of SET and MYND domain-containing protein 2 (SMYD2). SMYD2 functions as a histone methyltransferase that methylates both histones and non-histone proteins, including p53/TP53 and RB1 [, ]. It specifically methylates histone H3 'Lys-4' (H3K4me) and dimethylates histone H3 'Lys-36' (H3K36me2). It plays a role in myofilament organisation in both skeletal and cardiac muscles via Hsp90 methylation []. SMYD2 overexpression is associated with tumour cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas []. It regulates leukemia cell growth such that diminished SMYD2 expression upregulates SET7/9, thereby possibly shifting leukemia cells from growth to quiescence state associated with resistance to DNA damage associated with Acute Myeloid Leukemia (AML) [].The SMYD family consists of five members including SMYD1/2/3/4/5. They contain two highly conserved structural and functional domains, the SET and MYND domains. The SET domain is involved in lysine methylation, while the MYND domain is involved in protein-protein interaction. They are essential in several mammalian developmental pathways [, , , ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Hollern DP |
Year: |
2019 |
Journal: |
Breast Cancer Res Treat |
Title: |
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer. |
Volume: |
174 |
Issue: |
1 |
Pages: |
143-155 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kent LN |
Year: |
2017 |
Journal: |
J Clin Invest |
Title: |
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. |
Volume: |
127 |
Issue: |
3 |
Pages: |
830-842 |
|
•
•
•
•
•
|
Publication |
First Author: |
Akeno N |
Year: |
2017 |
Journal: |
Mol Cancer Ther |
Title: |
TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response. |
Volume: |
16 |
Issue: |
12 |
Pages: |
2913-2926 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shi M |
Year: |
2020 |
Journal: |
Biol Reprod |
Title: |
Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis. |
Volume: |
102 |
Issue: |
5 |
Pages: |
1055-1064 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamamoto K |
Year: |
2015 |
Journal: |
Leukemia |
Title: |
Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice. |
Volume: |
29 |
Issue: |
6 |
Pages: |
1414-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ihler F |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Expression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen. |
Volume: |
7 |
Issue: |
1 |
Pages: |
e29846 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun M |
Year: |
2017 |
Journal: |
Cancer Res |
Title: |
HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. |
Volume: |
77 |
Issue: |
19 |
Pages: |
5313-5326 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pajovic S |
Year: |
2011 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties. |
Volume: |
52 |
Issue: |
10 |
Pages: |
7618-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu Z |
Year: |
2015 |
Journal: |
J Clin Invest |
Title: |
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy. |
Volume: |
125 |
Issue: |
1 |
Pages: |
425-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Veras MA |
Year: |
2019 |
Journal: |
J Cell Physiol |
Title: |
Loss of ENT1 increases cell proliferation in the annulus fibrosus of the intervertebral disc. |
Volume: |
234 |
Issue: |
8 |
Pages: |
13705-13719 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lyu P |
Year: |
2020 |
Journal: |
Exp Cell Res |
Title: |
Unveiling the transcriptome alteration of POMC neuron in diet-induced obesity. |
Volume: |
389 |
Issue: |
1 |
Pages: |
111848 |
|
•
•
•
•
•
|
Publication |
First Author: |
Allaman-Pillet N |
Year: |
2017 |
Journal: |
Oncotarget |
Title: |
Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model. |
Volume: |
8 |
Issue: |
9 |
Pages: |
15490-15506 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu X |
Year: |
2019 |
Journal: |
Autophagy |
Title: |
Gene essentiality of Tubgcp4: dosage effect and autophagy regulation in retinal photoreceptors. |
Volume: |
15 |
Issue: |
10 |
Pages: |
1834-1837 |
|
•
•
•
•
•
|
Publication |
First Author: |
Smith AP |
Year: |
2003 |
Journal: |
Comp Med |
Title: |
Switching of melanocyte pigmentation associated with pituitary pars intermedia tumors in Rb+/- and p27-/- female mice with yellow pelage. |
Volume: |
53 |
Issue: |
1 |
Pages: |
75-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tonks ID |
Year: |
2006 |
Journal: |
Pigment Cell Res |
Title: |
Pocket protein function in melanocyte homeostasis and neoplasia. |
Volume: |
19 |
Issue: |
4 |
Pages: |
260-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ding L |
Year: |
2008 |
Journal: |
Nature |
Title: |
Somatic mutations affect key pathways in lung adenocarcinoma. |
Volume: |
455 |
Issue: |
7216 |
Pages: |
1069-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ledent C |
Year: |
1995 |
Journal: |
Oncogene |
Title: |
Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene. |
Volume: |
10 |
Issue: |
9 |
Pages: |
1789-97 |
|
•
•
•
•
•
|
Publication |
First Author: |
Flowers S |
Year: |
2014 |
Journal: |
Bone |
Title: |
p107-Dependent recruitment of SWI/SNF to the alkaline phosphatase promoter during osteoblast differentiation. |
Volume: |
69 |
|
Pages: |
47-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fatema K |
Year: |
2024 |
Journal: |
Cancers (Basel) |
Title: |
Arid1a Loss Enhances Disease Progression in a Murine Model of Osteosarcoma. |
Volume: |
16 |
Issue: |
15 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Li Z |
Year: |
2019 |
Journal: |
J Biol Chem |
Title: |
A novel thyroid hormone receptor isoform, TRβ2-46, promotes SKP2 expression and retinoblastoma cell proliferation. |
Volume: |
294 |
Issue: |
8 |
Pages: |
2961-2969 |
|
•
•
•
•
•
|
Publication |
First Author: |
Oser MG |
Year: |
2019 |
Journal: |
Genes Dev |
Title: |
The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis. |
Volume: |
33 |
Issue: |
23-24 |
Pages: |
1718-1738 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cemeli T |
Year: |
2019 |
Journal: |
J Pathol |
Title: |
Cytoplasmic cyclin D1 regulates glioblastoma dissemination. |
Volume: |
248 |
Issue: |
4 |
Pages: |
501-513 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao H |
Year: |
2017 |
Journal: |
Oncogene |
Title: |
p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer. |
Volume: |
36 |
Issue: |
1 |
Pages: |
60-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen J |
Year: |
2022 |
Journal: |
Oncogene |
Title: |
Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium. |
Volume: |
41 |
Issue: |
1 |
Pages: |
138-145 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang S |
Year: |
2022 |
Journal: |
Front Cell Dev Biol |
Title: |
The cell cycle inhibitor RB is diluted in G1 and contributes to controlling cell size in the mouse liver. |
Volume: |
10 |
|
Pages: |
965595 |
|
•
•
•
•
•
|